mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.04 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.04 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.04 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.04 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.58 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |